- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03112239
Chronic Effects Using Light-Emitting Diode Therapy (LEDT) During a Resistance Exercise Protocol for Asthmatic Patients
Chronic Effects Using Light-Emitting Diode Therapy (LEDT) During a Resistance Exercise Protocol for Moderate to Severe Asthmatic Patients: a Randomized Controlled Clinical Trial.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
This research project will be prospective, analytical and of the randomized controlled clinical trial type, with blind evaluator. The sample type will be consecutive from Santa Casa de Misericórdia de São Paulo. We will study 30 adults of both sexes with moderate to severe asthma between the ages of 20 and 70, based on the sample calculation of the outcomes of this study.
Adult individuals 20 years of age or older with a diagnosis of moderate to severe asthma of both sexes, attended at the Ambulatory of Difficult Asthma Control of Santa Casa de Misericórdia de São Paulo.
Exclusion terms include subjects diagnosed as having heart disease associated with pulmonary disease, musculoskeletal pathology that may interfere with assessment or exercise, pulmonary hypertension, calcium absorption deficiency, BMI ≥ 30 or difficulty learning.
The subjects will initially be pre-evaluated by performing pulmonary function tests, peripheral muscle strength (1-RM), functional capacity tests, physical activity questionnaires and clinical control of asthma and cardiopulmonary exercise test. After the evaluation, patients will be randomized into two resistance training groups, one of them associated with active LED phototherapy and another LED phototherapy placebo.
The resistance exercise protocol will be performed on the muscles: Pectoral, Large Dorsal, Brachial Biceps, Brachial Triceps, Quadriceps and Tibial Ischia. The intensity will be from 40 to 70% obtained in the 1-RM test with two to three sets of ten repetitions.
The load increase will be performed weekly (5%) according to patient tolerance. After 12 weeks all subjects were reevaluated and the last reevaluation occurred at the end of the training program. Patients will only effectively begin participating in this study after explaining the terms of the survey and by accepting written consent from the ICF.
The mean (in kg) of the resistance training protocol for lower limbs in knee extension of group 1 was 33 ± 13 kg and the mean of group 2 was 46 ± 11 kg. The sample calculation was based on the load of the quadriceps muscle, α = 0.05 and β = 95%, determining a minimum of fourteen individuals for each group. An additional 10% was added to compensate for possible losses during the protocol. Thus a minimum of fifteen individuals will be required for the study.
Linear regression models will be used to evaluate the effect of the LED on the results (absolute change and percentage) and a sensitivity analysis with the values of the results in the revaluation, adjusted by the initial value of each result. The possible correlations between the variables can be evaluated using Pearson's correlation. The level of significance adopted will be p <0.5. The analyzes were performed with SPSS 20 software.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
São Paulo, Brasil, 05415-012
- Ivan Peres Costa
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients with a medical outpatient setting less than six months; With a stable clinical picture during three months, ie without exacerbations and with optimized drug therapy.
Signed an informed consent form (TCLE) accepting participation in the research.
Exclusion Criteria:
- Diagnosis of heart disease associated with lung disease, musculoskeletal disease that may interfere with assessment or exercise, pulmonary hypertension, calcium absorption deficiency, BMI ≥ 30, or difficulty learning.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: photobiomodulation by active LEDT
The subjects will be initially pre-evaluated by performing pulmonary function tests, peripheral muscle strength tests, functional capacity tests, physical activity questionnaires and clinical control of asthma, and cardiopulmonary exercise test.
After the evaluation, patients will be randomized into two resistance training groups, one of them being associated to the intervention with active photobiomodulation by LEDT to increase peripheral muscle function post resistance training.
|
Light-emitting diode, has effects similar to the photobiomodulation by low-level laser intensity.
Outros nomes:
|
|
Comparador de Placebo: photobiomodulation by Placebo LEDT
The subjects will be initially pre-evaluated by performing pulmonary function tests, peripheral muscle strength tests, functional capacity tests, physical activity questionnaires and clinical control of asthma, and cardiopulmonary exercise test.
After the evaluation, patients will be randomized into two resistance training groups, one of them being associated to the intervention with placebo LEDT photobiomodulation to increase peripheral muscle function post resistance training.
|
Light-emitting diode, has effects similar to the photobiomodulation by low-level laser intensity.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pectoral Muscular Strength by 1RM.
Prazo: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the pectoral muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Major Dorsal Muscular Strength by 1RM
Prazo: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the major dorsal muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Femoral Quadriceps Muscular Strength by 1RM
Prazo: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the femoral quadriceps muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Brachial Triceps Muscular Strength by 1RM
Prazo: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the brachial triceps muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Brachial Biceps Muscular Strength by 1RM
Prazo: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the brachial biceps muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
|
Tibial Ischia Muscular Strength by 1RM
Prazo: Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Muscle strength will be assessed in the tibial ischia muscle group, using the maximal repetition (1RM) test to quantify the resistance training load (between 60 and 80%).
|
Change from Baseline Peripheral muscular Strength up to 24 weeks.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Functional Capacity by Cardiopulmonary exercise test.
Prazo: Change from baseline measured by cardiopulmonary exercise test up to 24 weeks.
|
The cardiopulmonary test will be performed in an electricomagnetic braking cycle ergometer connected to a system composed of gas analysis module attached to a module flow/wave analyzer and a microcomputer BreezeCardiO2 System.
(medical Graphics Corporation - MGC, St. Paul, Mo, USA).
|
Change from baseline measured by cardiopulmonary exercise test up to 24 weeks.
|
|
Functional Capacity by Incremental Shuytle Walk Test.
Prazo: Change from baseline measured by Incremental Shuttle Walk Test distance up to 24 weeks.
|
The incremental shuttle walk test was performed based on the original test description.
The patient walk from side to side in a space of 10 meters identified by two cones inserted 0.5 from each end to avoid such sudden changes in speed.
The participant was instructed to walk from cone to cone in one.
A single point that the participant must keep pace and a triple beep indicates the beginning of a new level, the height at which the participant has increased the pace.
The test comprised 12 levels, each lasting one minute.
The speed of the first level was 1.8 Km/h, with an increase of 0.17 m/s every minute until reaching a top speed of 8.53 Km/h.
The test was stopped when the participant was unable to reach the cone before the next beep.
|
Change from baseline measured by Incremental Shuttle Walk Test distance up to 24 weeks.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Luciana MM Sampaio, PhD, University of Nove de Julho
Publicações e links úteis
Publicações Gerais
- Miranda EF, Leal-Junior EC, Marchetti PH, Dal Corso S. Acute effects of light emitting diodes therapy (LEDT) in muscle function during isometric exercise in patients with chronic obstructive pulmonary disease: preliminary results of a randomized controlled trial. Lasers Med Sci. 2014 Jan;29(1):359-65. doi: 10.1007/s10103-013-1359-5. Epub 2013 Jun 7.
- Dourado VZ, Tanni SE, Antunes LC, Paiva SA, Campana AO, Renno AC, Godoy I. Effect of three exercise programs on patients with chronic obstructive pulmonary disease. Braz J Med Biol Res. 2009 Mar;42(3):263-71. doi: 10.1590/s0100-879x2009000300007.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- ERAMG-LED-PL-01
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Treinamento de Resistência
-
Ataturk UniversityConcluídoMindfulness Compassionate Living TrainingPeru
-
Memorial Sloan Kettering Cancer CenterConcluídoComskil TrainingEstados Unidos
-
University of PennsylvaniaNational Center for Complementary and Integrative Health (NCCIH)ConcluídoSem condição | Focus is Neural Effects of Mindfulness Training on AttentionEstados Unidos
-
Ataturk UniversityAinda não está recrutandoMindfulness Compassionate Living Training
Ensaios clínicos em Light-Emitting Diode Therapy (LEDT)
-
Chang Gung Memorial HospitalNational Taipei University of Nursing and Health SciencesConcluídoFadiga | Qualidade do Sono | Sobreviventes de câncer ginecológico | Sintomas de humorTaiwan
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RetiradoCarcinoma Espinocelular Recidivante de Lábio e Cavidade Oral | Carcinoma Espinocelular Recidivante de Orofaringe | Carcinoma Verrucoso Recorrente da Cavidade Oral | Carcinoma de Células Escamosas Estágio I do Lábio e Cavidade Oral | Carcinoma de Células Escamosas Estágio I de Orofaringe | Carcinoma... e outras condiçõesEstados Unidos
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)ConcluídoCâncer de Pulmão de Células Não Pequenas Recorrente | Câncer de pulmão de células não pequenas estágio 0 | Câncer de pulmão de células escamosas | Adenocarcinoma do Pulmão | Câncer de Pulmão de Células GrandesEstados Unidos
-
Roswell Park Cancer InstituteConcluídoCâncer recorrente de tireoide | Câncer Folicular de Tireóide Estágio II | Câncer Papilífero de Tireóide Estágio II | Câncer de Pescoço Escamoso Metastático Recorrente com Primário Oculto | Câncer de glândula salivar recorrente | Carcinoma Espinocelular Recidivante de Hipofaringe | Carcinoma Espinocelular... e outras condiçõesEstados Unidos
-
Cairo UniversityConcluídoMucosite oral (ulcerativa)Egito
-
VA Office of Research and DevelopmentPortland VA Medical CenterRecrutamentoTranstorno de Estresse Pós-Traumático | Lesão cerebral traumática leveEstados Unidos
-
Jordan Miller, PT, PhDInvitalizeConcluídoOsteoartrite, JoelhoCanadá
-
The University of Hong KongChinese University of Hong Kong; University of Oxford; Flinders UniversityRecrutamentoInsônia | Fase de sono atrasadaHong Kong
-
King's College LondonKings Health PartnersConcluídoDepressão | Transtorno Depressivo Maior | Depressão Unipolar | Depressão ModeradaReino Unido
-
National Cancer Institute (NCI)RescindidoCâncer de Próstata Recorrente | Câncer de Próstata Estágio I | Adenocarcinoma da Próstata | Câncer de Próstata Estágio IIA | Câncer de Próstata Estágio IIBEstados Unidos